15:59 May 19

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1018.90
+27.80 (+2.81%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd. Financials

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1018.90
+27.80 (+2.81%)
15:59 May 19
Quality
image/svg+xml

45/100
Medium Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

10

Weakness

4

Opportunity

1

Threats

0

18.58 %

ROE %

9.61 %

ROA %

50.09

EPS

269.50

BVPS

18.56 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
15265.2 17237.4 19547.4 23241.5 27148.4
Operating Expenses +
11924.5 13377.5 14163.1 16183 18673.3
Raw Material
5907.5 6072 6478.4 6522.9 8180.1
Increase Decrease in Cost
-362.3 238.1 -250.2 -184.9 -887.5
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2434.1 2765.6 3137.6 3680.6 4417.9
Miscellaneous Expenses
7674.4 8200.6 8593.1 10464.4 13103.8
Operating Profit
3340.7 3859.9 5384.3 7058.5 8475.1
Other Income
224.7 186.6 284.1 269.5 509.5
Depreciation
713 722.7 764.1 915.8 1408
Interest
127 129.9 81.2 165.9 438.9
Profit before tax and exceptio..
2725.4 3193.9 4823.1 6246.3 7137.7
Exceptional Items
112.7 -604.2 -14.2 -219.6 -516.6
PBT
2838.1 2589.7 4808.9 6026.7 6621.1
Provision for Taxation
511.7 587.8 977.5 1411.9 1594.7
Net Profit
4572.1 1997.3 3854.4 4614.8 5026.4
NET Profit after MI
4487.3 1960.3 3859.5 4525.5 5040
EPS
43.83 19.3 38.14 44.97 50.09
Operating Profit Margin (%)
21.88 22.39 27.54 30.37 31.22
Net Profit Margin (%)
29.4 11.37 19.74 19.47 18.56

Zydus Lifesciences Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 75.00 75.00 75.00 75.00 75.00 75.00
FII 7.00 7.10 7.30 7.10 7.30 7.50
Public 11.20 11.00 10.90 11.20 11.00 10.70
Others 6.80 6.90 6.80 6.70 6.70 6.80
Shareholder Shares Holding %
Download Our App On: